Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · December 12, 2013

Topical Rapamycin Effective for Angiofibroma

The British Journal of Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

The British Journal of Dermatology
First Left-Right Comparative Study of Topical Rapamycin Versus Vehicle for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex
Br J Dermatol 2013 Dec 01;169(6)1314–1318, M Tanaka, M Wataya-Kaneda, A Nakamura, S Matsumoto, I Katayama

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading